Budget 2018-19

  Ace investor Rakesh Radheshyam Jhunjhunwala held 10.82 per cent stake in Nazara Technologies as on June 30, 2021 Rakesh Jhunjhunwala’s holding value in Nazara Technologies crossed Rs 1,000 crore mark as the stock rallied 19 per cent on the BSE in Friday’s intra-day trade. In the past one month, the market price of Nazara Technologies, diversified gaming and sports media platform, has zoomed 78 per cent. In comparison, the S&P BSE Sensex was up 3 per cent during the same period. Ace investor Rakesh Radheshyam Jhunjhunwala held a 10.82 per cent stake in Nazara Technologies as of June 30, 2021. Based on intra-day high, the company’s market capitalisation stood at Rs 9,800 crore while  Rakesh Jhunjhunwala ’s net worth in the company came in at Rs 1,060 crore. Shares of Nazara Technologies hit a new high of Rs 3,223.80 in intra-day trade today, surging 39 per cent in the past one week. The stock was quoting higher for the seventh straight trading day. On Wednesday, October 6,...

Tata Steel BSL’s consolidated net profit more-than-doubled to Rs 1,913 crore in Q4FY21, against Rs 913 crore in December quarter (Q3FY21) Shares of  Tata Steel  were up 5 per cent at Rs 936.50 on the BSE in intra-day trade on Thursday after Tata Steel BSL, a subsidiary of the company, reported a strong operational performance for the quarter ended March 2021 (Q4FY21). The stock of Tata Steel BSL surged 6 per cent to Rs 61.25 in intra-day trade, quoting close to its 52-week high of Rs 62 touched on April 8. Tata Steel BSL’s consolidated net profit more-than-doubled to Rs 1,913 crore in Q4FY21, against Rs 913 crore in December quarter (Q3FY21). Consolidated revenue from operations jumped 24 per cent to Rs 7,321 crore from Rs 5,881 crore in the previous quarter. Earnings before interest, taxes, depreciation and amortization (Ebitda) grew 25 per cent at Rs 257 crore on a sequential basis. The beat on Ebitda was driven by higher-than-expected volumes and realisation. Sales volumes ...

  Orchid Pharma shares were locked in the upper circuit for the 96th straight trading day Shares of  Orchid Pharma  were locked in the upper circuit for the 96th straight trading day, up 5 per cent at Rs 1,839.65 on the BSE in Friday’s session. The stock has zoomed 102 times or 10,120 per cent from the level of Rs 18 since its relisting on November 3, 2020. Currently, Orchid Pharma is trading under the T group on the BSE. In the T2T segment, each trade has to result in delivery and no intra-day netting of positions is allowed. The company has a total of 40.81 million outstanding shares, of which 98.04 per cent or 40.01 million shares are with the promoter Dhanuka Laboratories, according to the December 2020 shareholding pattern data. Dhanuka Laboratories took over the pharma company under the National Company Law Tribunal (NCLT) resolution process. The public shareholders held a mere 1.93 per cent holding in the firm, of which 1.19 per cent stake was with the financial in...